戻る
Northwest Biotherapeutics Inc (NWBO)価格
NWBO 株価推移チャート
NWBO 収入
Northwest Biotherapeutics Inc
$0.3
5.93%
$0.01
終値： Jan 16, 16:00:00 GMT-5
$0.3
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.2832
始値
$0.2898
当日レンジ
$0.2826 - $0.301
52週レンジ
$0.17 - $0.48
取引高
1.5M
平均取引高
3.8M
1株当たり利益(TTM)
-0.06
配当利回り
--
時価総額
$458.6M
NWBOとは何ですか？
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. The company is headquartered in Bethesda, Maryland and currently employs 25 full-time employees. The company went IPO on 2001-12-14. The firm is focused on developing personalized immune therapies for cancer. The company has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The firm's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. The company has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.